Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis

Hepatology

Volumn 26, Issue 1, 1997, Pages 81-89

  Matsuda, Yasunobu ^a,b   Matsumoto, Kunio ^a   Yamada, Akira ^a   Ichida, Takafumi ^b   Asakura, Hitoshi ^b   Komoriya, Yasunobu ^c   Nishiyama, Eiji ^c   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c TOYOBO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CHOLESTASIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYPOALBUMINEMIA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTO ONCOGENE; RAT;

EID: 0030915038     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260111     Document Type: Article

References (49)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
2. Russell WE, McGowan JA, Bucher NLR. Partial characterization of hepatocyte growth factor from rat platelets. J Cell Physiol 1984;119:183-192.
3. Thaler J, Michalopoulos GK. Hepatopoietin A: a partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res 1985; 45:2545-2549.
4. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991;3:67-85.
5. Michalopoulos GK, Zarnegar R. Hepatocyte growth factor. HEPATOLOGY 1992;15:149-155.
6. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncogenesis 1992;3:27-54.
7. Jiang WG, Hallett MB, Puntis MCA. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 1993;80:1368-1373.
8. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxines. Biochem Biophys Res Commun 1989;165:1229-1234.
9. Zarneger R, DeFrances MC, Kost DP, Lindroos P, Michalopoulos GK. Expression of hepatocyte growth factor mRNA in regenerative rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177: 559-565.
10. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. HEPATOLOGY 1991;13:1-5.
11. Shiota G, Okano J, Kawasaki H, Kuwamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. HEPATOLOGY 1995;21:106-112.
12. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and for potent anti-hepatitis action in vivo. HEPATOLOGY 1992;16:1227-1235.
13. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. HEPATOLOGY 1993;18:1443-1449.
14. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa TK, et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 1995;117:1105-1112.
15. Roos F, Terrell TG, Godowski PJ, Chamow SW, Schwall RH. Reduction of alpha-naphtylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 1992;131:2540-2544.
16. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1993;1155:357-371.
17. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995;345:293-295.
18. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995;129:1177-1180.
19. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996;119:591-600.
20. Gherardi E, Stoker M. Hepatocyte growth factor-scatter factor: mitogen, motogen, and Met. Cancer Cells 1991;3:227-232.
21. Weidner KM, Arakaki N, Hartmann G, Vanderkerkhove J, Weingart S, Rieder H, Fonatsch C, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991;88:7001-7005.
22. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991;67:901-908.
23. Johnson M, Koukoulis G, Matsumoto K, Nakamura T, Iyer A. HGF induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. HEPATOLOGY 1993;17:1052-1061.
24. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-804.
25. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarneger R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the protooncogene c-met. Oncogene 1991;6:501-504.
26. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
27. Seki T, Ihara I, Sugimura A, Shimonishi M, Nishizawa T, Asami O, Hagiya M, et al. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocytes. Biochem Biophys Res Commun 1990;172:321-327.
28. Rubin E, Hutterer F, Popper H. Experimental hepatic fibrosis without hepatocellular regeneration. Am J Pathol 1968;52:111-119.
29. Geerts A, Schellink P, Bouwens L, Wisse E. Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic carbon tetrachloride administration. J Hepatol 1988;6:50-56.
30. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. HEPATOLOGY 1989;10:84-92.
31. Miao S, Bao-En W, Annoni G, Degli Esposti S, Biempica L, Zern MA. Two rat models of hepatic fibrosis: a morphologic and molecular composition. Lab Invest 1990;63:467-475.
32. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967;19:249-255.
33. Jenkins SA, Grandison A, Baxter JN, Day DW, Taylor I, Shields R. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol 1985;1:489-499.
34. Jézéquel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 1987;5:174-181.
35. Takehara T, Matsumoto K, Nakamura T. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J Biochem 1992;112:330-334.
36. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995;118:643-649.
37. Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 1987;262:6443-6446.
38. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
39. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133:1042-1050.
40. Strain AJ, Frazer A, Hill DJ, Milner RD. Transforming growth factor-β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun 1987;145:436-442.
41. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β 1. Proc Natl Acad Sci U S A 1992;89:5408-5412.
42. Sanchez A, Alvarez AM, Benito M, Fabregat I. Apoptosis induced by transforming growth factor-β in fetal hepatocytes primary cultures: involvement of reactive oxygen intermediates. J Biol Chem 1996;271: 7416-7422.
43. Russell RE, Coffey RJ Jr, Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988;85:5126-5130.
44. Weiner FR, Giambrone M, Czaja MJ, Shah A, Annoni G, Takahashi S, Eghbali M, et al. Ito-cell gene expression and collagen synthesis. HEPATOLOGY 1990;11:111-117.
45. Bachem MG, Meyer DM, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells - a potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992;89:19-27.
46. Czaja MJ, Weiner FR, Flanders KC, Giambrone M, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factor-β 1 with hepatic fibrosis. J Cell Biol 1989;108:2477-2482.
47. Nakatsukasa H, Nagy P, Everts RP, Hsia C, Marsden E, Thorgeisson SS. Cellular distribution of transforming growth factor-β 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990;85:1833-1843.
48. Takehara T, Nakamura T. Protective effect of hepatocyte growth factor on in vitro hepatitis in primary cultured hepatocytes. Biomed Res 1991; 12:335-338.
49. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. HEPATOLOGY 1996;24:636-642.